The Danish Medicines Agency has not identified any safety issues with the prescribed cannabis products included in the programme.
The country's first harm-reduction training sessions took place in November.
The monograph will be used to provide new specifications and standards for cannabis-based medicines in Europe.
Reports suggest the Macron government will not support general legalisation when the medical cannabis experiment ends in 2024.
Revised legislation is expected to be submitted to the government in August.
Draft proposals to be debated in parliament this month are expected to include a 5g daily limit and a compulsory register of consumers.
Little Green Pharma which provides up to 60% of the prescribed products has pulled out of the trial.
Zurich will be the second Swiss city to legalise the sale and consumption of limited amounts of cannabis for personal use.
But recreational consumers will face further criminalisation.
The Maltese Authority for the Responsible Use of Cannabis (ARUC) has announced the criteria for opening a cannabis club.
